Please login to the form below

Not currently logged in


This page shows the latest lawsuit news and features for those working in and with pharma, biotech and healthcare.

First Humira biosimilars reach EU market

First Humira biosimilars reach EU market

report. Lawsuits involving other biosimilar adalimumab developers – namely Amgen, Samsung Bioepis and Sandoz – were resolved on the understanding that they did not launch in the US until the 2023 patent expiry.

Latest news

More from news
Approximately 9 fully matching, plus 322 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    investors. However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made

  • Market access improvements in Turkey Market access improvements in Turkey

    Industry successfully filed a lawsuit against the Ministry of Health for the lack of updates.

  • Pharma deals during December 2014 Pharma deals during December 2014

    Acquisitions are frequently complicated by external factors and a day after the Merck acquisition was announced Cubist lost its Cubicin patent infringement lawsuit against Hospira in the US.

  • Healthcare industry apps Healthcare industry apps

    In addition, Amazon has recently opened its own 'App Store' (Apple is currently contesting Amazon's use of the term App Store in a US lawsuit) for its Kindle Fire tablet

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    Takeda also faces lawsuits involving alleged side effects of Actos. Last year, the US Food and Drug Administration reported that longterm Actos users were at a slightly increased risk of developing

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Article: The Colombia Conundrum

    More than 346, 000 lawsuits of this nature were raised between 2006 and 2008, with courts usually deciding in favor of the patients. ... As the number of lawsuits increased exponentially in the following years, the healthcare system was plunged into

  • Clinical data Transparency

    Amidst extensive criticism the pharmaceutical industry has called for more carrot as an incentive for companies to begin releasing their data; and in the face of two lawsuits even the European

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...